![Chris Stevens](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chris Stevens
Plus aucun poste en cours
Historique de carrière de Chris Stevens
Anciens postes connus de Chris Stevens
Sociétés | Poste | Début | Fin |
---|---|---|---|
ASTRIA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/10/2021 | 15/07/2022 |
Arsanis, Inc.
![]() Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | Directeur Technique/Scientifique/R&D | 01/06/2016 | 15/01/2019 |
Alnara Pharmaceuticals, Inc.
![]() Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/01/2009 | 01/01/2011 |
Altus Pharmaceuticals, Inc.
![]() Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Directeur Technique/Scientifique/R&D | - | - |
CB Biomedical, Inc.
![]() CB Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services CB Biomedical, Inc. develops and produces novel bioartificial organs based on proprietary mammalian cell and semi permeable membrane technologies. The company is headquartered in Lexington, MA | Directeur Technique/Scientifique/R&D | - | - |
Harvard Medical School | Corporate Officer/Principal | - | - |
Formation de Chris Stevens
The University of North Carolina at Charlotte | Undergraduate Degree |
University of Miami | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 9 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 4 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ASTRIA THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Arsanis, Inc.
![]() Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | Health Technology |
Alnara Pharmaceuticals, Inc.
![]() Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA. | Health Technology |
CB Biomedical, Inc.
![]() CB Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services CB Biomedical, Inc. develops and produces novel bioartificial organs based on proprietary mammalian cell and semi permeable membrane technologies. The company is headquartered in Lexington, MA | Commercial Services |
Altus Pharmaceuticals, Inc.
![]() Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Health Technology |
- Bourse
- Insiders
- Chris Stevens
- Expérience